https://parkinsonsnewstoday.com/?p=95095
0
0
11/13/23 at 1:24pm
Organization
Parkinson's News Today
Author
Andrea Lobo
Vaxxinity says its vaccine, UB-312, given Parkinson’s patients in Phase 1 trial induced alpha-synuclein antibodies to slow protein toxicity.
Create an account
or login to join the discussion